Better Artificial Intelligence Stock: Astera Labs vs. NVIDIA

The article contrasts AI infrastructure plays: Astera Labs revenue rose 115.1% to $852.5M in FY2025 with $219.1M net income and $281.8M free cash flow, but it faces high customer concentration (top customer >70%). NVIDIA delivered vastly larger scale with FY2026 revenue up 65.5% to $215.9B and FCF of $96.7B, while projecting 70% YoY revenue growth next fiscal year; it also trades at a lower valuation versus Astera (Forward P/E 24.2x vs 67.0x; P/S 18.1x vs 40.8x). Despite risks around export controls and competition for NVIDIA and supply-chain/customer concentration for Astera, the piece’s implied portfolio call favors NVIDIA as the better value for 2026.

Analysis

The key market mechanism here is not “AI demand,” but where the spend shifts as clusters get denser. That favors NVDA because it owns the primary budget line item and can absorb some substitution into software, interconnect, and system-level products; it is the cleaner way to express the capex cycle with lower execution risk. ALAB can still compound faster on a percentage basis, but its upside is more fragile because one customer/design cycle can dominate the P&L, so a single reorder delay can create an air pocket even if industry demand stays strong.

The hidden winner in a maturing AI build-out may be the networking/interconnect stack, but the market is already paying an extreme multiple for that optionality in ALAB. The quality issue is that reported cash generation is less clean than it looks because stock comp is doing a lot of the heavy lifting; that matters if the stock transitions from “story” to “fundamentals” over the next 2-4 quarters. By contrast, NVDA’s scale and software lock-in give it more pricing power and a better chance to defend margin if hyperscalers push harder on custom silicon.

Contrarian take: consensus may be underestimating how quickly compute vendors can internalize or commoditize adjacent connectivity spend, which caps ALAB’s long-run moat. On the other hand, consensus may also be underestimating how long the capex wave can persist if model training/inference demand keeps pulling on both GPUs and the network fabric. The thesis is falsified for NVDA if next guidance implies a material step-down in growth or export controls hit mix; it is falsified for ALAB if customer concentration translates into even modest revenue deceleration or gross margin compression over the next 1-2 quarters.

Key Decisions for Investors

• Prefer long NVDA over ALAB on a 1-3 month and 6-12 month horizon: buy NVDA on any pullback toward the low end of its post-earnings range and use ALAB strength to fade the relative valuation gap; risk/reward favors the cheaper, higher-quality compounder with less single-customer risk.
• Pair trade: long NVDA / short ALAB for a relative-value view over the next 2-4 quarters. The pair benefits if AI capex broadens but the market stops paying peak multiples for niche connectivity; stop if ALAB demonstrates sustained multi-customer diversification or materially better gross margin expansion.
• Avoid initiating a fresh ALAB position ahead of the next quarterly print unless you have evidence of customer diversification and non-SBC-adjusted FCF conversion. The stock likely needs another beat-and-raise to justify the current multiple; failure to raise guidance is the main downside catalyst.
• Watch MSFT and AMZN internal silicon programs as a medium-term negative for both NVDA and ALAB, but more for ALAB on the connectivity side if hyperscalers standardize around in-house architectures. If custom hardware adoption accelerates, reduce exposure to the smaller supplier names first.
• For optionality, use a small NVDA call spread into the next product-cycle catalyst rather than outright ALAB longs; NVDA has better liquidity and a cleaner path to multiple support if growth remains above 60% y/y. Falsify if delivery constraints or export controls cut into the next guide.